ZA858077B - 2-substituted amino-4(1h)-pyrimidone derivatives,process for producing them,and medical compositions containing them - Google Patents

2-substituted amino-4(1h)-pyrimidone derivatives,process for producing them,and medical compositions containing them

Info

Publication number
ZA858077B
ZA858077B ZA858077A ZA858077A ZA858077B ZA 858077 B ZA858077 B ZA 858077B ZA 858077 A ZA858077 A ZA 858077A ZA 858077 A ZA858077 A ZA 858077A ZA 858077 B ZA858077 B ZA 858077B
Authority
ZA
South Africa
Prior art keywords
producing
compositions containing
substituted amino
medical compositions
pyrimidone derivatives
Prior art date
Application number
ZA858077A
Other languages
English (en)
Inventor
Isao Yanagisawa
Mitsuaki Ohta
Tokuichi Takagi
Makoto Takeuchi
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of ZA858077B publication Critical patent/ZA858077B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA858077A 1984-12-28 1985-10-21 2-substituted amino-4(1h)-pyrimidone derivatives,process for producing them,and medical compositions containing them ZA858077B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59277760A JPS61155373A (ja) 1984-12-28 1984-12-28 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法

Publications (1)

Publication Number Publication Date
ZA858077B true ZA858077B (en) 1986-06-25

Family

ID=17587950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858077A ZA858077B (en) 1984-12-28 1985-10-21 2-substituted amino-4(1h)-pyrimidone derivatives,process for producing them,and medical compositions containing them

Country Status (4)

Country Link
EP (1) EP0186275A3 (ja)
JP (1) JPS61155373A (ja)
ES (1) ES548074A1 (ja)
ZA (1) ZA858077B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0613486B2 (ja) * 1987-12-07 1994-02-23 株式会社池田模範堂 ピリミドン誘導体及びその医薬的に許容される塩
US9161803B2 (en) 2010-11-05 2015-10-20 Ethicon Endo-Surgery, Inc. Motor driven electrosurgical device with mechanical and electrical feedback
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
JPS597177A (ja) * 1982-07-06 1984-01-14 Teikoku Hormone Mfg Co Ltd 新規な置換ベンジルアミン誘導体
JPS60228465A (ja) * 1984-04-26 1985-11-13 Yamanouchi Pharmaceut Co Ltd 新規な４（１ｈ）−ピリミドン誘導体及びその製造方法

Also Published As

Publication number Publication date
EP0186275A2 (en) 1986-07-02
EP0186275A3 (en) 1987-05-20
ES548074A1 (es) 1987-02-16
JPS61155373A (ja) 1986-07-15

Similar Documents

Publication Publication Date Title
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
PT81015B (en) Process for the preparation of piridazo-diazocine derivatives and pharmaceutical compositions therewith
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
DE3267673D1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same
PH18979A (en) Banzazepine derivatives,their pharmaceutical compositions and method of use
GB2099817B (en) Azetidinone derivatives and process for the preparation of the same
IL74232A0 (en) 2-cyanobenzimidazole derivatives,process for their preparation and pesticidal compositions comprising the same
EP0169712A3 (en) New pyrimidine derivatives, processes for preparation thereof and composition containing the same
EP0177287A3 (en) Pyrimidine derivatives, processes for preparation thereof and composition of the same
DE3264523D1 (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methyl phenol, process for their preparation and their use as medicines
ZA822344B (en) Derivatives of 2-piperazino pyrimidine, methods for their preparation and their utilization as drugs or intermediates for the manufacture of drugs
PT83033B (en) Process for the preparation of pyridine derivatives and of fungicidal compositions therewith
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
DE3560528D1 (en) Novel 2-substituted 3-sulphopropyl-ammoniumbetaines and process for their preparation
JPS6480287A (en) Novel compound, method for manufacture of the same and drug composition containing the same
DE3260932D1 (en) Process for the preparation of derivatives of resorcin, and the use of certain derivatives of resorcin as perfumes
ZA858077B (en) 2-substituted amino-4(1h)-pyrimidone derivatives,process for producing them,and medical compositions containing them
IL74373A0 (en) Process for the preparation of diaminopyridines
GB2109377B (en) Uracil derivatives, process for their preparation, and medicinal composition containing same
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
PT79990A (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
ZA852554B (en) Novel substituted benzodioxole derivatives,processes for their manufacture and corresponding pharmaceutical compositions
DE3562012D1 (en) Pyrimidinediones and dihydroxypyrimidines, and process for the preparation of pyrimidinedones and dihydroxypyrimidines
PT81157A (en) Process for the preparation of aromatic-1,4-oxazepinones and thiones
EP0161548A3 (en) Process for the preparation of riboflavin, and intermediates for this process